Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
Description: NARRATIVE Peripheral arterial disease (PAD), an illness commonly found in the elderly and caused by arterial occlusion in the lower body, affects more than 200 million people worldwide and is associated with high rates of morbidity and mortality. To reduce these complications and improve the quality of life for PAD patients, our research aims to develop novel biodegradable nanoparticles to deliver therapeutic agents that specifically protect cells under ischemic stress conditions, facilitate the formation of blood vessels under hypoxia, and facilitate noninvasive multimodal imaging methods, such as fluorescent and photoacoustic imaging, to monitor the progress of this therapeutic intervention. The impact of our research is significant as these new nanoparticle platforms could be used to deliver any therapeutics locally, treat this disease effectively, and monitor the treatment noninvasively by imaging.
Funding type: research
Funder scheme: R01
Start date: 2022-05-02
End date: 2027-04-30
Investigator: LI LIU (lead)
Institutions: The University of Texas at Arlington, UNIVERSITY OF TEXAS ARLINGTON
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Funded outputs count: 15
Funder award ID: R01HL158204
OpenAlex ID: G9000885666
